Fund profile by ISIN IE000QYDXKV5
VanEck Morningstar Developed Markets ex-US Dividend Leaders UCITS ETF A USD Acc
Research VanEck Morningstar Developed Markets ex-US Dividend Leaders UCITS ETF A USD Acc by ISIN IE000QYDXKV5: TER 0.38%, domicile Ireland, accumulating, and 1-year price performance -8.3%.
ISINIE000QYDXKV5
TER0.38%
DomicileIreland
Distribution policyAccumulating
IndexMorningstar Developed Markets ex-US Large Cap Dividend Leaders Screened Select
Fund size27M
Holdings100
1-year price performance-8.3%
Exchange listings and tradability
| Ticker | Exchange | Currency | Country | Avg daily turnover | Avg daily shares |
|---|---|---|---|---|---|
| TDVX.DE | XETRADefault at German brokers | EUR | Ireland | €142K | 7,784 |
| TDVX.MI | ETFP | EUR | Ireland | €58K | 3,168 |
| TDVX.SW | SW | CHF | Ireland | €22K | 1,185 |
Avg daily turnover is the 90-day average, converted to euros so venues in different currencies can be compared; avg daily shares is the same window in units. The most traded listing is shown first. This fund trades on a German exchange. As of 2026-10-12.
Largest holdings
The 10 largest holdings make up 33.55% of the fund, which holds 100 positions in total. As of 2026-10-12.
| Holding | Symbol | Weight |
|---|---|---|
| Shell PLC | SHEL.L | 4.58% |
| Novartis AG Registered Shares | NOVN.SW | 4.21% |
| Nestle SA | NESN.SW | 4.19% |
| TotalEnergies SE | TTE.PA | 4.01% |
| HSBC Holdings PLC | HSBA.L | 3.93% |
| Unilever PLC | ULVR.L | 2.62% |
| BP PLC | BP.L | 2.61% |
| Allianz SE | ALV.DE | 2.57% |
| Sanofi SA | SAN.PA | 2.45% |
| Novo Nordisk AS Class B | NOVO-B.CO | 2.39% |
Performance is the historical price return of the representative listing. Distributions are excluded and past performance is not a forecast.